Celldex Therapeutics Inc
NASDAQ:CLDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
Pernod Ricard SA
PAR:RI
|
FR |
|
Harmony Gold Mining Company Ltd
F:HAM1
|
ZA |
|
C
|
CITIC Securities Co Ltd
F:CI9
|
CN |
|
Abb Ltd
MIL:1ABB
|
CH |
|
Ranpak Holdings Corp
NYSE:PACK
|
US |
|
Thungela Resources Ltd
F:6UP
|
ZA |
|
Cass Information Systems Inc
NASDAQ:CASS
|
US |
|
Roche Holding AG
SIX:ROG
|
CH |
|
International Paper Co
NYSE:IP
|
US |
|
A
|
Apollo Investment Corp
F:55O1
|
US |
|
A
|
AT&T Inc
F:SOBA
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
I
|
Iron Mountain Inc
F:I5M
|
US |
|
C
|
Canadian National Railway Co
XMUN:CY2
|
CA |
|
R
|
Radian Group Inc
F:RAG
|
US |
|
Janus Living Inc
NYSE:JAN
|
US |
|
C
|
Compagnie Generale des Etablissements Michelin SCA
XHAM:MCH
|
FR |
|
I
|
International Paper Co
BMV:IP
|
US |
|
Z
|
Zijin Mining Group Co Ltd
F:FJZB
|
CN |
|
M
|
Macy's Inc
SWB:FDO
|
US |
Wall St Price Targets
CLDX Price Targets Summary
Celldex Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CLDX is 58.208 USD with a low forecast of 34.34 USD and a high forecast of 105 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLDX's stock price target?
Price Target
58.208
USD
According to Wall Street analysts, the average 1-year price target for
CLDX is 58.208 USD with a low forecast of 34.34 USD and a high forecast of 105 USD.
What is the Revenue forecast for Celldex Therapeutics Inc?
Projected CAGR
147%
Over the last 13 years, the compound annual growth rate for Revenue has been -14%. The projected CAGR for the next 8 years is 147%.